About the Author Tony Medrano is CEO and co-founder of LongevityPlan.AI, a platform that integrates performance and health data from athletes and leverages proprietary Cardiorespiratory Digital Twin technology, wearable data, and biomarker data to deliver personalized performance optimization and longevity recommendations to athletes, coaches, organizations, businesses, government, and the military
IGF-1, as happens with other hormone therapies (thyroid hormone or insulin), should never been used lightly without firstly assessing its deficiency (local, central or systemic) and secondly by ascertaining that no tumours are near to be generated
Particularly beneficial for patients with insulin resistance or PCOS in weight management programs
A.EvansC
10.1046/j.1365-2036.2002.01152.x 79
(Archived 7/24/2017) A: PPS will report on this for DY2 Q4, which is the quarter ending March 30 th , 2017